Calcium score CAC vs Carotid IntimaMedia Thickness CIMT in predicting cardiovascular events - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Calcium score CAC vs Carotid IntimaMedia Thickness CIMT in predicting cardiovascular events

Description:

Affects management in statin therapy, pre-op, etc. ... Intermediate CVD risk (ie, 6% 20% 10-year risk of event by Framingham data) ... – PowerPoint PPT presentation

Number of Views:219
Avg rating:3.0/5.0
Slides: 22
Provided by: micha117
Category:

less

Transcript and Presenter's Notes

Title: Calcium score CAC vs Carotid IntimaMedia Thickness CIMT in predicting cardiovascular events


1
Calcium score (CAC) vs Carotid Intima-Media
Thickness (CIMT) in predicting cardiovascular
events
GIM Conference June 17th, 2009 Presented by
Michael Luc
Folsom AR, Kronmal RA, Detrano RC, et al.
Coronary artery calcification compared with
carotid intima-media thickness in the prediction
of cardiovascular disease incidence the
Multi-Ethnic Study of Atherosclerosis (MESA).
Arch Intern Med. 2008168(12)13331339.
www.kgu.de/zrad, vanha.med.utu.fi
2
Background The Detection Gap
  • 10-year risk of CVD event traditionally
    determined by risk factors only
  • Affects management in statin therapy, pre-op,
    etc.
  • However, 1/3 of CVD events are not predicted by
    traditional (Framingham) risk factors
  • Other Methods to assess for atherosclerosis
  • Serum biomarkers CRP, IL-6, MMP1, lipoprotein
    a, homocysteine, fibrinogen
  • Imaging carotid intima-media thickness (CIMT),
    coronary artery calcium score (CAC)

Gerber, TC and Taylor, AJ. Carotid Intima-Media
Thickness Can it Close the Detection Gap for
Cardiovascular Risk? Mayo Clinic Proceedings.
March 200984(3)218-220.
3
2008 ASE Recommendations for Caroitid-Intima
Media Thickness Scanning
  • Consider scanning in patients aged 4070 years,
    without a condition that indicates high CVD risk,
    AND
  • Intermediate CVD risk (ie, 620 10-year risk of
    event by Framingham data)
  • Family history of premature CVD in a first-degree
    relative
  • Individuals older than 60 years with severe
    abnormalities in a single risk factor who
    otherwise would not be candidates for
    pharmacotherapy
  • Women younger than 60 years with less than 2 CVD
    risk factors
  • Imaging should not be performed if the results
    would not be expected to alter therapy.

Stein JS, Korcarz CE, Post WS. Use of Carotid
Ultrasound to Identify Subclinical Vascular
Disease and Evaluate Cardiovascular Disease Risk
Summary and Discussion of the American Society of
Echocardiography Consensus Statement. Preventive
Cardiology. Winter 2009. 34-38.
4
2007 ACC/AHA Expert Consensus on Coronary Artery
Calcium (CAC) Score
  • It may be reasonable to consider use of CAC
    measurement in asymptomatic patients with
    intermediate CHD risk (between 10 and 20 events
    per 10-yrs) if
  • it would classify patients into a higher risk
    status
  • AND if subsequent patient management would be
    modified.
  • CAC scanning is not recommended in high or low
    risk groups.

Greenland P, Bonow RO, Brundage BH, et al
American College of Cardiology Foundation
Clinical Expert Consensus Task Force (ACCF/AHA
Writing Committee to Update the 2000 Expert
Consensus Document on Electron Beam Computed
Tomography) Society of Atherosclerosis Imaging
and Prevention Society of Cardiovascular
Computed Tomography. ACCF/AHA 2007 clinical
expert consensus document on coronary artery
calcium scoring by computed tomography in global
cardiovascular risk assessment and in evaluation
of patients with chest pain a report of the
American College of Cardiology Foundation
Clinical Expert Consensus Task Force (ACCF/AHA
Writing Committee to Update the 2000 Expert
Consensus Document on Electron Beam Computed
Tomography). Circulation. 2007115(3)402-426.
5
Study Objectives
  • This study is the largest to date comparing CIMT
    vs CAC score using outcomes data
  • Objectives
  • To determine the ability of CIMT and CAC to
    predict CVD events after correction for
    traditional risk factors
  • To determine which is better to predict CVD
    events

6
Methods
  • Study design - Prospective cohort study
  • Exclusion criteria - Anyone with CVD
  • Patients received maximum carotid IMT and CAC
    score at baseline in 2000-2002
  • Six field centers in major cities in the U.S.
  • Endpoints - Risk of new CVD events including
    coronary heart disease, stroke, and death from
    CVD
  • Follow-up Greatest follow-up was 5 years

7
Results
  • Age - 45 to 84 years
  • Ethnic groups - white (38), black (28),
    Hispanic (22), or Asian (12)
  • n6698 (analyzed out of 6,814 that were
    recruited)
  • 222 CVD (CHD and stroke) events detected in 5
    yrs.
  • 159 CHD events (61 cases of myocardial
    infarction, 81 cases of angina, 3 cases of
    resuscitated cardiac arrest, 13 CHD deaths)
  • 59 stroke events (some had overlap with CHD
    events)

8
Analysis
  • Overall, CAC score was more strongly associated
    with CVD events than IMT
  • Variables standardized in order to normalize
    distributions for better comparison
  • ln(CAC score 1)
  • z-score of maximum CIMT (number of SD away from
    mean)

9
Risks of Overall Events (n222) with an elevated
CAC score or CIMT Hazard Ratios
  • Adjustment for age, sex, and race - Hazard ratios
    (95 CI) for each 1 standard deviation increase
  • Standardized CIMT 1.3 (1.1-1.4)
  • Standardized CAC score 2.1 (1.8-2.5)
  • Adjustment for all risk factors (age, sex, race,
    smoking, diabetes, blood pressure, lipids, and
    statin use)
  • Standardized CIMT 1.2 (1.0-1.3)
  • Standardized CAC score 1.9 (1.6-2.2)

10
Risks of MI, Angina, or Cardiac Death (n159)
with an elevated CAC score or CIMT Hazard Ratios
  • Adjustment for age, sex, and race - Hazard ratios
    (95 CI) for each 1 standard deviation increase
  • Standardized CIMT 1.1 (1.0-1.4)
  • Standardized CAC score 2.5 (2.1-3.1)
  • Adjustment for all risk factors (age, sex, race,
    smoking, diabetes, blood pressure, lipids, and
    statin use)
  • Standardized CIMT 1.1 (1.0-1.3)
  • Standardized CAC score 2.3 (1.9-2.8)

11
Risks of Stroke (n59) with an elevated CAC score
or CIMT Hazard Ratios
  • Adjustment for age, sex, and race - Hazard ratios
    (95 CI) for each 1 standard deviation increase
  • Standardized CIMT 1.4 (1.2-1.8)
  • Standardized CAC score 1.1 (0.8-1.5)
  • Adjustment for all risk factors (age, sex, race,
    smoking, diabetes, blood pressure, lipids, and
    statin use)
  • Standardized CIMT 1.3 (1.1-1.7)
  • Standardized CAC score 1.1 (0.8-1.4)

12
Risks of Overall Events in Framingham
Intermediate-Risk Group ONLY (n81) with an
elevated CAC score or CIMT Hazard Ratios
  • Adjustment for all risk factors (Age, sex, race,
    smoking, diabetes, blood pressure, lipids, and
    statin use)
  • Standardized CIMT 1.4 (1.1-1.6)
  • Standardized CAC score 1.8 (1.4-2.2)

13
(No Transcript)
14
Discussion
  • In asymptomatic 45-84 y.o. US adults, CAC score
    may be better than CIMT for screening of those
    with intermediate risk.
  • Also, on the side, in this MESA study there are
    substantial ethnic differences in CAC score
    (highest in whites) and to a lesser degree for
    IMT (highest in African Americans).

15
Discussion Strengths
  • Multiethnic sample
  • Standardization across multiple centers
  • Adjustment for traditional risk factors
  • Reliance on outcomes data of events (MI, death,
    angina) vs surrogate end points such as
    subclinical atherosclerosis

16
Discussion Weaknesses
  • Relatively short follow-up period (5 years)
  • Relatively small number of strokes in study
  • Statistical distribution difference between IMT
    and CAC, with 50 of CAC score being 0
  • Outcomes data incl. angina with MI and death
  • Patients informed of CAC and IMT scores at
    baseline may have influenced pts to alter risk
    factors, especially since 17 of those with high
    CAC score were referred to their primary MDs vs
    1 of those with high IMT.

17
Conclusion
  • In conclusion, although whether and how to use
    bioimaging tests for subclinical atherosclerosis
    remains a topic of debate, this study found that
    CAC score was a better predictor of subsequent
    CVD events than was carotid IMT.

18
Application Screening?
  • WHO Screening criteria (1968)
  • x Important health problem
  • x Accepted treatment for recognized disease
  • x Facilities for diagnosis and treatment
  • x Suitable latent and symptomatic stage
  • x Suitable test or examination
  • x Natural history of condition understood
  • x Agreed on policy on whom to treat
  • x Case finding should be continuous process
  • Cost of finding economically balanced with
    overall health does it add that much over
    traditional RF?
  • Test acceptable to population

19
Application Clinical practice
  • More data is needed, more event data before a
    rigorous cost-benefit analysis can be done
  • Consider differences in radiation exposure, cost,
    and availability
  • IMT can be done in office with handheld and is
    cheaper overall but requires more operator skill
    (ultrasound)
  • CAC requires radiation exposure but from this
    study is a better predictor of cardiac events

20
Thank you!
  • Questions?

21
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com